126 related articles for article (PubMed ID: 6678555)
1. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
[No Abstract] [Full Text] [Related]
2. Carvedilol for portal hypertension in patients with cirrhosis.
Bosch J
Hepatology; 2010 Jun; 51(6):2214-8. PubMed ID: 20513005
[No Abstract] [Full Text] [Related]
3. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
[TBL] [Abstract][Full Text] [Related]
4. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
[TBL] [Abstract][Full Text] [Related]
5. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Vorob'ev LP; Maev IV; Andreev NG
Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
[TBL] [Abstract][Full Text] [Related]
6. [Medical therapy of portal hypertension due to liver cirrhosis].
Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
[No Abstract] [Full Text] [Related]
8. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
[TBL] [Abstract][Full Text] [Related]
9. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Schneider AW; Kalk JF; Klein CP
Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
[TBL] [Abstract][Full Text] [Related]
10. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
Merkel C; Sacerdoti D; Finucci GF; Zuin R; Bazzerla G; Bolognesi M; Gatta A
Br J Clin Pharmacol; 1986 Jun; 21(6):713-9. PubMed ID: 3741719
[TBL] [Abstract][Full Text] [Related]
11. Long term effects of propranolol on portal pressure in cirrhotic patients.
Orban-Schiopu AM; Popescu CR
Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological treatment of the portal hypertension].
Castañeda Romero B
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
[No Abstract] [Full Text] [Related]
13. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
[No Abstract] [Full Text] [Related]
14. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
[No Abstract] [Full Text] [Related]
15. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
[TBL] [Abstract][Full Text] [Related]
16. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
Vorob'ev LP; Maev IV
Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073
[TBL] [Abstract][Full Text] [Related]
17. Losartan in preascitic cirrhosis.
Castaño G; Viudez P; Sookoian S
Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016
[No Abstract] [Full Text] [Related]
18. [Our experience on the clinical use of nadolol].
Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
[No Abstract] [Full Text] [Related]
19. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E
Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061
[No Abstract] [Full Text] [Related]
[Next] [New Search]
